药明康德一季报业绩大增昨日晚间,CXO龙头药明康德发布一季报,公司营收净利均实现双位数增长,实现营业收入96.55亿元,同比增长20.96%;实现归母净利润36.72亿元,同比增长89.06%;每股收益1.29元,同比增长92.54%。值得注意的是,这是公司自2022年第四季度以来,首次实现营收净利润双位数增长。对于归母净利润大幅增长的原因,公司表示,主要系在保持营业收入增长的同时,不断优化...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.